Legend Biotech Corp at ASCO 2023 Transcript
Ying Huang, followed by data presentations on the CARTITUDE-4, CARTITUDE-1 and (inaudible) Legend-2. And then we will open up for Q&A. For those joining us virtually, please feel free to type in your questions in the chat box at any time, and we'll try to get to as many as we can before the hour. Participating in the Q&A today are our 2 KOLs, Dr. Binod Dhakal from the Medical College of Wisconsin and Dr. Shambavi Richard from Mount Sinai. And then from Legend, we are joined by Ying Huang, CEO; Steve Gavel, Head of Commercial Development; and Nitin Patel, Executive Medical Director of Clinical Development.
Before I turn the meeting over to Ying, I do need to mention that we will be making forward-looking statements today. These are discussed in our filings with the SEC, which can be found under the Investors section of our website. Thank you.
Good morning, everyone, and thank you for coming and joining us today. So my name is Ying Huang, and I'm excited to speak with you about our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
